AUPH
$17.33+2.54%
Aurinia Pharmaceuticals IncStock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.006% of ONEQRussell 3000 · 0.003% of IWV
Aurinia Pharmaceuticals Inc total returns by year (including dividends)
As of market close, Oct 22, 2026
Aurinia Pharmaceuticals Inc total returns by year (2015–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $15.95 | $17.33 | 0.0% | +8.7% | |
| 2025 | $8.98 | $15.95 | 0.0% | +77.6% | |
| 2024 | $8.99 | $8.98 | 0.0% | -0.1% | |
| 2023 | $4.32 | $8.99 | 0.0% | +108.1% | |
| 2022 | $22.87 | $4.32 | 0.0% | -81.1% | |
| 2021 | $13.83 | $22.87 | 0.0% | +65.4% | |
| 2020 | $20.26 | $13.83 | 0.0% | -31.7% | |
| 2019 | $6.82 | $20.26 | 0.0% | +197.1% | |
| 2018 | $4.53 | $6.82 | 0.0% | +50.6% | |
| 2017 | $2.10 | $4.53 | 0.0% | +115.7% | |
| 2016 | $2.47 | $2.10 | 0.0% | -15.0% | |
| 2015 | $3.64 | $2.47 | 0.0% | -32.1% |
- Annualized
- +15.0%
- 2015–2026
- Average year
- +41.3%
- 11 full years
- Best year
- +197.1%
- 2019
- Worst year
- -81.1%
- 2022
- Positive years
- 6/11
- 55% up
Annualized (CAGR)
+15.0%
2015–2026
Average year
+41.3%
11 full years
Best year
+197.1%
2019
Worst year
-81.1%
2022
Positive years
6/11
55% up
Total return by period#
Annual
-100%0%100%
2015-32%'15
2016-15%'16
2017+116%'17
2018+51%'18
2019+197%'19
2020-32%'20
2021+65%'21
2022-81%'22
2023+108%'23
2024-0.11%'24
2025+78%'25
2026+8.7%'26
Methodology#
Total returns, dividends reinvested, measured on AUPH. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Aurinia Pharmaceuticals Inc's average annual return?
- Since 2015, Aurinia Pharmaceuticals Inc (AUPH) has returned about 15.0% a year (the compound annual growth rate) and an average calendar-year return of 41.3%.
- What were Aurinia Pharmaceuticals Inc's best and worst years?
- Over 2015–2026, the best year was 2019 (+197.1%) and the worst was 2022 (-81.1%).
- How often is Aurinia Pharmaceuticals Inc up in a year?
- 6 of the 11 full years since 2015 were positive — about 55% of the time.
More on Aurinia Pharmaceuticals Inc
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100